TWIST1 methylation by SETD6 selectively antagonizes LINC-PINT expression in glioma.

Nucleic Acids Res

The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105 Be'er-Sheva, Israel.

Published: July 2022

Gliomas are one of the most common and lethal brain tumors among adults. One process that contributes to glioma progression and recurrence is the epithelial to mesenchymal transition (EMT). EMT is regulated by a set of defined transcription factors which tightly regulate this process, among them is the basic helix-loop-helix family member, TWIST1. Here we show that TWIST1 is methylated on lysine-33 at chromatin by SETD6, a methyltransferase with expression levels correlating with poor survival in glioma patients. RNA-seq analysis in U251 glioma cells suggested that both SETD6 and TWIST1 regulate cell adhesion and migration processes. We further show that TWIST1 methylation attenuates the expression of the long-non-coding RNA, LINC-PINT, thereby promoting EMT in glioma. Mechanistically, TWIST1 methylation represses the transcription of LINC-PINT by increasing the occupancy of EZH2 and the catalysis of the repressive H3K27me3 mark at the LINC-PINT locus. Under un-methylated conditions, TWIST1 dissociates from the LINC-PINT locus, allowing the expression of LINC-PINT which leads to increased cell adhesion and decreased cell migration. Together, our findings unravel a new mechanistic dimension for selective expression of LINC-PINT mediated by TWIST1 methylation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262621PMC
http://dx.doi.org/10.1093/nar/gkac485DOI Listing

Publication Analysis

Top Keywords

twist1 methylation
16
twist1
8
cell adhesion
8
linc-pint locus
8
expression linc-pint
8
linc-pint
7
expression
5
glioma
5
methylation setd6
4
setd6 selectively
4

Similar Publications

Cardiovascular diseases (CVDs) and cerebrovascular diseases (CeVDs) are closely related vascular diseases, sharing common cardiometabolic risk factors (RFs). Although pleiotropic genetic variants of these two diseases have been reported, their underlying pathological mechanisms are still unclear. Leveraging GWAS summary data and using genetic correlation, pleiotropic variants identification, and colocalization analyses, we identified 11 colocalized loci for CVDs-CeVDs-BP (blood pressure), CVDs-CeVDs-LIP (lipid traits), and CVDs-CeVDs-cIMT (carotid intima-media thickness) triplets.

View Article and Find Full Text PDF

Background: Bladder urothelial carcinoma (BLCA), like other cancers, is strongly associated with genetic and epigenetic changes. TWIST1 is an epithelial-mesenchymal transition (EMT) promoter that has been linked to the development of many malignancies. It is still unclear, however, what role TWIST1 plays in BLCA, and the relationship between TWIST1 transcript levels and its promoter methylation and immune infiltration has been reported even less.

View Article and Find Full Text PDF

Promotor Hypomethylation Mediated Upregulation of VCAN Targets Twist1 to Promote EndMT in Hypoxia-Induced Pulmonary Hypertension.

J Am Heart Assoc

December 2024

Department of Respiratory Medicine The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University Wuxi Jiangsu People's Republic of China.

Article Synopsis
  • Hypoxia-induced pulmonary hypertension (HPH) involves a process called endothelial-to-mesenchymal transition (EndMT), with the gene versican potentially playing a key role in its development.
  • Research methods included various techniques to assess versican expression and EndMT, revealing that higher levels of versican correlated with HPH progression and vascular changes in both mice and humans.
  • The study concluded that increased versican, linked to reduced DNA methylation, promotes EndMT by affecting the transcription factor Twist1, indicating a potential new target for HPH treatment.
View Article and Find Full Text PDF

The role of TGF-β signaling in the epigenetic modifications involved in ovarian cancer is not fully understood. This study investigated the relationship between TGF-β signaling, epigenetic modifications, and cellular behaviors in ovarian cancer. We found that E-cadherin, a key cell adhesion molecule, underwent epigenetic silencing via promoter DNA hypermethylation in ovarian cancer cell lines and that this was accompanied by the upregulation of vimentin, which is indicative of a mesenchymal and invasive phenotype.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the genetic landscape of non-small cell lung cancer (NSCLC) and its impact on resistance to osimertinib, using liquid biopsy to identify resistance mechanisms.
  • It analyzed plasma-circulating free DNA (cfDNA) and circulating tumor cells (CTCs) from 30 NSCLC patients, detecting various molecular alterations that could indicate resistance to treatment.
  • Findings revealed discrepancies in the mutation presence between cfDNA and CTCs, suggesting that combining both analyses provides a broader understanding of resistance and potential treatment options.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!